Feature|Articles|July 4, 2025

Regulatory recap: FDA approvals in urology from the first half of 2025

Fact checked by: Benjamin P. Saylor, Strategic Content Lead

Take a look through all the regulatory milestones in urology from the first half of the 2025.

The first half of 2025 ushered in several FDA approvals across urology, reflecting the growing momentum and innovation in the space. With key FDA nods across bladder cancer, prostate cancer, incontinence, and more, the treatment landscape continues to evolve across a broad range of conditions.